Exact Sciences Stock Investor Sentiment

EXAS Stock  USD 49.31  1.28  2.53%   
Slightly above 75% of EXACT Sciences' investor base is looking to short. The analysis of the overall investor sentiment regarding EXACT Sciences suggests that many traders are alarmed. EXACT Sciences' investing sentiment can be driven by a variety of factors including economic data, EXACT Sciences' earnings reports, geopolitical events, and overall market trends.

Comfort Level 25

 Alarmed

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use EXACT Sciences' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward EXACT Sciences.

EXACT Historical Sentiment

Although EXACT Sciences' investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding EXACT, such as negative comments on social media and news outlets, may cause fear in the market and push EXACT Sciences' investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of EXACT.
  

EXACT Sciences Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards EXACT Sciences can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

EXACT Sciences Historical Investor Sentiment

Investor biases related to EXACT Sciences' public news can be used to forecast risks associated with an investment in EXACT. The trend in average sentiment can be used to explain how an investor holding EXACT can time the market purely based on public headlines and social activities around EXACT Sciences. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
EXACT Sciences' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for EXACT Sciences and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average EXACT Sciences news discussions. The higher the estimate score, the more favorable the investor's outlook on EXACT Sciences.

EXACT Sciences Maximum Pain Price Across April 17th 2025 Option Contracts

EXACT Sciences' options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of EXACT Sciences close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of EXACT Sciences' options.
17 hours ago at thelincolnianonline.com         
Quantum Private Wealth LLC Sells 16,499 Shares of Exact Sciences Co.
news
2 days ago at kalkinemedia.com         
How Is Exact Sciences Engaging Institutional Investors and Expanding Diagnostic Solutions
news
3 days ago at zacks.com         
Guardant Health Expected to Beat Earnings Estimates Can the Stock Move Higher?
zacks News
few days ago at finance.yahoo.com         
When Can We Expect A Profit From Exact Sciences Corporation?
Yahoo News
over a week ago at gurufocus.com         
Exact Sciences Corp Trading Down 3.19 percent on Feb 7
Gurufocus Stories at Macroaxis
over a week ago at thelincolnianonline.com         
Exact Sciences Co. Given Average Recommendation of Moderate Buy by Brokerages
news
over a week ago at gurufocus.com         
Dentsply Sirona Appoints Michael Barber and Daniel Scavilla as New Board Members
Gurufocus Stories at Macroaxis
over a week ago at simplywall.st         
The past five years for Exact Sciences investors has not been profitable
Simply Wall St News at Macroaxis
over a week ago at zacks.com         
Amgen Q4 Earnings and Revenues Surpass Estimates
zacks News
over a week ago at businesswire.com         
Exact Sciences Schedules Fourth Quarter 2024 Earnings Call
businesswire News
over a week ago at gurufocus.com         
Exact Sciences Corp Announces Fourth Quarter 2024 Financial Results Release Date
Gurufocus Stories at Macroaxis
over two weeks ago at news.google.com         
Disposition of tradable shares by Coward D Scott of EXACT Sciences at 60.15 subject to Rule 16b-3
Google News at Macroaxis
over two weeks ago at thelincolnianonline.com         
Slow Capital Inc. Purchases 5,346 Shares of Exact Sciences Co.
news
over two weeks ago at news.google.com         
Exact Sciences Liquid Biopsy Threat Is Solidifying - Seeking Alpha
Google News at Macroaxis
over three weeks ago at thelincolnianonline.com         
Barclays Begins Coverage on Exact Sciences
news
Far too much social signal, news, headlines, and media speculation about EXACT Sciences that are available to investors today. That information is available publicly through EXACT media outlets and privately through word of mouth or via EXACT internal channels. However, regardless of the origin, that massive amount of EXACT data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of EXACT Sciences news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of EXACT Sciences relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to EXACT Sciences' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive EXACT Sciences alpha.

EXACT Sciences Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Exact Sciences Advances Breast Cancer Care with the Oncotype DX test and Genomic Profiling Research at SABCS 2024
11/25/2024
2
Acquisition by Orville Jacob A of 4724 shares of EXACT Sciences subject to Rule 16b-3
12/02/2024
3
Geode Capital Management LLC Buys 7,873 Shares of Exact Sciences Co.
12/16/2024
4
Exact Sciences Corp Trading Down 7.21 percent on Jan 14
01/14/2025
5
2 Healthcare Stocks to Buy Hand Over Fist in January
01/16/2025
6
Exact Sciences Corp Stock Price Up 4.18 percent on Jan 21
01/21/2025
7
Acquisition by Brian Baranick of 21401 shares of EXACT Sciences subject to Rule 16b-3
01/22/2025
8
Exact Sciences Liquid Biopsy Threat Is Solidifying - Seeking Alpha
01/27/2025
9
Exact Sciences Corp Announces Fourth Quarter 2024 Financial Results Release Date
02/03/2025
10
The past five years for Exact Sciences investors has not been profitable
02/04/2025
11
Exact Sciences Co. Given Average Recommendation of Moderate Buy by Brokerages
02/07/2025
12
How Is Exact Sciences Engaging Institutional Investors and Expanding Diagnostic Solutions
02/14/2025

Additional Tools for EXACT Stock Analysis

When running EXACT Sciences' price analysis, check to measure EXACT Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EXACT Sciences is operating at the current time. Most of EXACT Sciences' value examination focuses on studying past and present price action to predict the probability of EXACT Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EXACT Sciences' price. Additionally, you may evaluate how the addition of EXACT Sciences to your portfolios can decrease your overall portfolio volatility.